Advances in Targeted Delivery of Nanomedicines
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 19
Special Issue Editor
Special Issue Information
Dear Colleagues,
Targeted and specific drug delivery has been especially challenging because of simultanous pathophysiologal mechanistic processes happening in vitro. For example, recording cancer-signalling pathophysiologal procesess would provide valuable infomation for the development of impactful therapeutics with high precision, which can provide therapy in challenging in-cellular environments plagued by drug resistance. This opens up new avenues for broadening existing nanoscience research by develo** novel nanomedicines with a high potential for clinical translation, as the superior endurance of nanomaterials (due to their chemical and photophysical attibutes) provides an additional edge over conventional therapeutics, which offers exciting prospects.
Dr. Sreejesh Sreedharan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at mdpi.longhoe.net by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicines
- drug delivery
- target delivery
- nanoscience
- cancer signalling
